Results: The results demonstrated that the multifunctional nanoparticles interfered with the expression of CAP1 and reduced NSCLC metastasis both in vitro and in vivo.
A small percentage of complications would inevitably occur in the performance of such an invasive procedure. The occurrence of pneumothorax and haemoptysis were the endpoints of concern, since significant pneumothorax would necessitate evacuation, and even minimal postprocedural haemoptysis would prove distressing to patients. This study aims to show the complication rates of CT-guided biopsy at our institution, as well as the predictors of said complications.
Methods: 2133 patients who underwent CT-guided transthoracic biopsy were included. Review of records determined occurrence of complications noted immediately post-biopsy. Patient age, biopsy type, and length of biopsy needle tract through the lung were analyzed to determine causality.
Results: Overall complication rate was 9.6%. Subjects that underwent FNAB had 4.01% pneumothorax rate and 5.7% haemoptysis rate.
Complication rates for core biopsy were 0% for Pneumothorax and 4.4% for haemoptysis. Chest tube placement was performed in 8.3% of pneumothorax. Only the distance traversed by the needle through the lung parenchyma showed a significant relationship with the occurrence of complications (P<0.001). Longer distances showed progressively higher odds for developing complications.
Conclusion: CT-guided transthoracic biopsy is a safe diagnostic tool. Only the biopsy tract length showed correlation with complication incidence, shown by increasing odds ratios with longer tracts (Adjusted OR starting at 2.501 for 0.2-1.0 cm [P = 0.013] to 8.297 for >4 cm [P = 0.000], with greatest OR of 9.709 for lengths of 3.1-4.0 cm [P = 0.000]) The complication rates immediately post-procedure at our institution are comparable to data in published literature. Due to older age with lung cancer was suggested had lower survival rate than younger age, not all of them treated by standard chemotherapy and radiotherapy. Correlation between older age and survival rate of patient with lung cancer still debatable. This study was aimed to know one-year survival rate in Non-Small Cell Lung Carcinoma (NSCLC) older's patients (Ages >60 years).
Methods: Data were obtained retrospectively from medical records patient in pulmonary ward, Dr. Sardjito Hospital, from 2015 to 2016. All patients meeting with inclusion criteria such as patients with NSCLC and age >18 years old were involved in this study. Ninety four subjects were collected consecutively. These data were analyzed statistically using SPSS 16. The Kaplan-Meier method was used for estimation of survival distribution and differences in survival were assessed by the log-rank statistic.
Results: Of the 94 patients analyzed, 48 patients were ≥ 60 years old and 46 patients were <60 years old. The mean of patients age was 59.11 AE 1.23 years old, with the younger was 30 years old and the oldest was 89 years old. There were 63 (67.02%) males and 31 (32.98%) females. The majority of NSCLC type were Squamous Cell carcinoma 27 (77.14%) and Adenocarcinoma 44 (46.81%). The staging ≥ III were 61 (64.89%) patients. There were 30 (31.91%) smokers. and 32 (60.38%) patients had comorbidity. The 1-year survival rates in younger and elderly patients were 22.92% and 19.57%, respectively. The median survival time of elderly patient was not significantly different with younger patients (6.00 vs 6.00 bulan; P = 0,718).
Conclusion:
Age was not the mayor prognostic factor impacting patient survival rate with NSCLC. Therefore, another factors should be considered, such as nutritional status and pulmonary function that require evaluation in elderly patients. that occurs in the visceral pleural is a rare and progressive cancer with poor patient prognosis.
Methods: An 80-year-old woman was admitted for dyspnea due to massive pleural effusion.
Results: Malignant cells were detected in the pleural effusion. Computed tomography and positron emission tomography findings did not reveal the intrapulmonary tumor, pleural thickening and the enlargement of lymph nodes. Immunohistochemical staining of collected cells in the pleural effusion showed MPM patterns. She was diagnosed with MPM of IMIG stage 1 and grade 1 performance status. Palliative care was selected because she had elderly and dementia. For improving dyspnea, the pleural effusion was extracted through a total of 82 thoracic puncture in last 10 years at the outpatient department and four times pleurodesis were also performed. However, large amounts of ascites were observed at age 87. The same malignant cells as in the pleural effusion were found in ascites, which was diagnosed as abdominal infiltration of MPM.
